Meeting
2022 ASCO Annual Meeting
Low skeletal muscle area and association with toxicity and hospitalization with chemotherapy in advanced non–small cell lung cancer.
Authors
Anurag Saraf
Harvard Radiation Oncology Program, Boston, MA
Anurag Saraf , John He , Kee-Young Shin , Jakob Weiss , Yu-Hui Chen , Paul J. Catalano , Mark M. Awad , David C. Christiani , Hugo Aerts , Raymond H. Mak
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 8532)
DOI
10.1200/JCO.2022.40.16_suppl.8532
Abstract #
8532
Poster Bd #
159
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Long-term outcomes of preoperative chemotherapy with modified DCS therapy for highly advanced gastric cancer with distant metastasis.
First Author: Atsushi Matsuki
Poster
2014 ASCO Quality Care Symposium
Effectiveness of cisplatin versus carboplatin-based doublet chemotherapy in elderly Medicare patients with advanced non-small cell lung cancer.
First Author: Elizabeth B. Lamont
Poster
2013 ASCO Annual Meeting
Different-dose docetaxel plus cisplatin as first-line chemotherapy and then maintenance therapy with single-agent docetaxel for advanced non-small cell lung cancer (TFINE study, C-TONG 0904).
First Author: Li Zhang
Poster
2011 ASCO Annual Meeting
Adoption of adjuvant chemotherapy (ACT) for non-small cell lung cancer (NSCLC) in the elderly: A population-based outcomes study.
First Author: S. Cuffe